Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Epistemonikos ID: cdc1016e3504e3d761e8b2b1d4a98e506f60130b
First added on: Oct 02, 2023